FIELD

Div. of Antivial Chemotherapy

Research outline

Graduate School  Joint Research Center for Human Retrovirus　Infection
Course  Health Research Course
Field  Infection and Immunity
Department  Division of Antiviral Therapy
Homepage http://www.kufm.kagoshima-u.ac.jp/~ccvd/retro/en/

Homepage

Contact

TEL.099-275-5931 /FAX.099- 275-5932

Research interests

  • The mission of our research group is to develop new therapeutics against certain refractory viral infections such as HIV and HBV. We also aim to establish novel strategies to combat with emerging diseases including COVID-19.  

Staff

馬場　昌範，BABA Masanori

Professor
Name Kenji MAEDA
Specialized field Drug development for HIV, HBV, CMV and COVID19
Research interests Cure of viral diseases such as AIDS 

Researche Repository

staff dummy

Associate Professor
Name  
Specialized field  
Research interests  

Researche Repository

staff dummy

Assistant Professor
Name  
Specialized field  
Research interests  

Repository

Research results

Kenji MAEDA

We have developed entry inhibitors (CCR5 inhibitors) that inhibit the entry of HIV into cells as a therapeutic drug for HIV-1 infections, and one of them (aplaviroc) have advanced to the clinical trial stage overseas. After that, we continued drug discovery research against various viruses such as HBV, CMV and SARS-CoV-2. Additionally, we have been conducting researches for HIV reservoirs toward HIV cure. We have also published many papers on clinical research for COVID-19.

 

Patents and copy Rights

title / application numberinventor / application date
 HIV感染症治療剤
2021-034428		 三隅 将吾、塚本 佐知子、岸本 直樹、人羅 勇気、
前田賢次　　　　　　　　　　　令和3年3月4日
COVID-19の重症化リスクに関する情報の取得方法、
SARS-CoV-2のS抗原に対するIgM抗体のモニタリング
方法、COVID-19の重症化リスクの判定を補助する方法
試薬キット、COVID-19の重症化リスクに関する情報の
取得装置及びCOVID-19重症化リスクに関する情報を
取得するためのコンピュータプログラム		  濱田哲暢、満屋裕明、前田賢次、野田健太　他
　　　　　　　　　　　　　　　令和3年2月22日
   
   

Collaborations

1）HIV drug development: Hirokazu Tamamura, Hiroaki Takeuchi (Tokyo Medical and Dental University)

2）HIV drug development and research for HIV cure: Yorifumi Satou, Shogo Misumi, Seiji Okada (Kumamoto University)

3）HIV reservoir analysis: Shinichi Oka, Hiroyuki Gatanaga, and Kiyoto Tsuchiya (National Center for Global Health and Medicine Hospital)

4）COVID-19: Norio Ohmagari (National Center for Global Health and Medicine Hospital)

Project・Event / Span研究
   
   
   
   
   
   
   
   
   
   
   
   
 

Homepage